Drugs & Pharmaceuticals M&A » By The Online Investor Staff, updated Mon., Jan. 24, 2:34 AM
Recent mergers and acquisitions in the Drugs & Pharmaceuticals M&A category.
| This Slide: #88 of 100 |
Slide #88. Teva Pharmaceutical Industries Ltd. — MicroDose Therapeutx
Acquirer:
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)
Acquiree:
MicroDose Therapeutx
Details:
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today announced that it has entered into a definitive agreement to acquire MicroDose Therapeutx, a privately-held pharmaceutical and drug delivery company focused on inhalation technologies and products for lung diseases and infections with the potential to dramatically improve efficacy and patient compliance.
Teva Pharmaceutical Industries is a pharmaceutical company. Co. operates through three segments: North America, which includes the U.S. and Canada; Europe, which includes the European Union and certain other European countries; and International Markets, which includes all countries in which Co. operates other than those in Co.'s North America and Europe segments. Co.'s products include: AUSTEDO; AJOVY (anti calcitonin gene-related peptide); COPAXONE; BENDEKA and TREANDA; ProAir HFA; ProAir RespiClick; QVAR; QVAR RediHaler; ProAir Digihaler; ArmonAir Digihaler; AirDuo Digihaler; BRALTUS®; CINQAIR/CINQAERO; and AirDuo RespiClick.
Open the TEVA Page at The Online Investor »
|
|||||||||||||||||||||
Open the TEVA Page at The Online Investor (in a new window) »
 Free TEVA Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
 
|
Hold (1.90 out of 4) 0th percentile
(ranked lower than approx. 100% of all stocks covered)
Analysts' Target Price: TEVA Stock Forecast Based on Zacks ABR data; powered by Xignite |
